ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

GANX Gain Therapeutics Inc

2.96
0.00 (0.00%)
プレマーケット
最終更新日: 20:50:17
15分遅延
名称 銘柄コード 市場 種別
Gain Therapeutics Inc GANX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 2.96 20:50:17
始値 安値 高値 終値 前日終値
2.96
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2422:25GLOBEGain Therapeutics Announces Positive Results from the Single..
2024/4/0822:25GLOBEGain Therapeutics Bolsters Management Team with the..
2024/4/0122:25GLOBEGain Therapeutics Strengthens Management Team and Appoints..
2024/3/2621:00GLOBEGain Therapeutics Reports Financial Results for Year End..
2024/3/1603:30GLOBEGain Therapeutics to Present at Public Ventures Discovery..
2024/3/0522:00GLOBEGain Therapeutics Presents Data at the AD/PD™ 2024..
2024/2/2804:00GLOBEGain Therapeutics Announces the Initiation of the Multiple..
2024/2/2221:00EDGAR2Form 8-K - Current report
2024/2/1502:29GLOBEGain Therapeutics Announces 2024 R&D Update on Parkinson’s..
2024/2/0623:56GLOBEUPDATE - Gain Therapeutics’ GT-02287 Completely Restores..
2024/2/0622:00GLOBEGain Therapeutics’ GT-02287 Completely Restores Motor..
2024/2/0107:26EDGAR2Form 8-K - Current report
2024/1/3122:00GLOBEGain Therapeutics’ CEO Matthias Alder Issues Letter to..
2024/1/0306:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/0222:00GLOBEGain Therapeutics Announces Acceptance of Late-Breaking..
2024/1/0214:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/2006:52EDGAR2Form S-1 - General form for registration of securities under..
2023/12/0122:00GLOBEGain Therapeutics Announces Preclinical Data Showing..
2023/11/2922:00GLOBEGain Therapeutics to Participate in AI Driven Drug Discovery..
2023/11/2503:01GLOBEGain Therapeutics Announces Closing of $10.1 Million Public..
2023/11/2420:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2307:27EDGAR2Form 8-K - Current report
2023/11/2122:54GLOBEGain Therapeutics Announces Pricing of $9.4 Million Public..
2023/11/2106:22EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/2106:03GLOBEGain Therapeutics Announces Proposed Public Offering
2023/11/1806:27EDGAR2Form 8-K - Current report
2023/11/1506:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1506:02EDGAR2Form 8-K - Current report
2023/11/1421:00GLOBEGain Therapeutics Announces Third Quarter 2023 Financial..
2023/10/0420:00GLOBEGain Therapeutics Announces Dosing of First Two Subjects in..
2023/9/2605:05GLOBEGain Therapeutics to Participate at Cantor Fitzgerald Global..
2023/9/2105:05GLOBEGain Therapeutics to Present at the Cambridge Healthtech..
2023/9/1222:25GLOBEGain Therapeutics Receives Approval to Commence Phase 1..
2023/8/1105:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:02EDGAR2Form 8-K - Current report
2023/8/1020:00GLOBEGain Therapeutics Announces Second Quarter 2023 Financial..
2023/8/0720:00GLOBEGain Therapeutics Announces Acceptance of Late Breaking..
2023/7/3121:00GLOBEGain Therapeutics to Participate in the 2023 BTIG Virtual..
2023/6/0121:00GLOBEGain Therapeutics to Present at the Jefferies Healthcare..
2023/5/1221:00GLOBEGain Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock